A review of health-related quality-of-life measures used in end-stage renal disease

Clinical Therapeutics

Volumn 18, Issue 5, 1996, Pages 887-938

  Edgell, Eric T ^a,b   Coons, Stephen Joel ^b   Carter, William B ^c   Kallich, Joel D ^c   Mapes, Donna ^c   Damush, Teresa M ^d   Hays, Ron D ^d,e  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c AMGEN INC   (United States)

^d RAND CORPORATION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; DISEASE ASSOCIATION; HEALTH; HUMAN; KIDNEY FAILURE; MEASUREMENT; MENTAL HEALTH; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SYMPTOM; TERMINAL DISEASE; TREATMENT OUTCOME;

EID: 0029906908     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(96)80049-X     Document Type: Article

References (129)

1. Opsahl JA, Guay DRP, Ptachcinski RJ. Chronic renal failure, end-stage renal disease, and renal transplantation. In: DiPiro JT, Talbert RL, Hayes PE. et al, eds. Pharmacotherapy: A Pathophysiologic Approach. New York: Elsevier Science Publishing Co, Inc; 1992:673-700.
2. Gokal R. Quality of life in patients undergoing renal replacement therapy. Kidney Int. 1993;43:S23-S27.
3. World Health Organization. The First Ten Years of the World Health Organization. Geneva: World Health Organization; 1958.
4. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York: Oxford University Press; 1992.
5. Guyatt GH, Veldhuyzen Van Zanten SJO, Feeny DH, Patrick DL. Measuring quality of life in clinical trials: A taxonomy and review. J Can Med Assoc. 1989;40: 1441-1448.
6. Hutchinson TA, Boyd NF, Feinstein AR. Scientific problems in clinical scales, as demonstrated in the Karnofsky Index of Performance Status. J Chronic Dis. 1979; 32:661-666.
7. Avram MR, Pena C, Burrell D, et al. Hemodialysis and the elderly patient: Potential advantages as to quality of life, urea generation, serum creatinine, and less interdialytic weight gain. Am J Kidney Dis. 1990;16:342-345.
8. Barrett BJ, Vavasour HM, Major A, Parfrey PS. Clinical and psychological correlates of somatic symptoms in patients on dialysis. Nephron. 1990;55:10-15.
9. Bjorvell H, Hylander B. Functional status and personality in patients on chronic dialysis. J Intern Med. 1989;226:319-324.
10. Delano BG. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients. Am J Kidney Dis. 1989;14:14-18.
11. Evans RW. Recombinant human erythropoietin and the quality of life of end-stage renal disease patients: A comparative analysis. Am J Kidney Dis. 1991;18: 62-70.
12. Evans RW, Manninen DL, Garrison LP Jr, et al. The quality of life of patients with end-stage renal disease. NEJM. 1985;312: 553-559.
13. Evans RW, Rader B, Manninen DL, The Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA. 1990;263:825-830.
14. Fukunishi I. Psychosomatic aspects of patients on hemodialysis: The relationship between quality of life and alexithymia. Psychother Psychosom. 1993;54:221-228.
15. Gutman RA, Stead WW, Robinson RR. Physical activity and employment status of patients on maintenance dialysis. NEJM. 1981;304:309-313.
16. Harris DC, Chapman JR, Stewart JH, et al. Low dose erythropoietin in maintenance haemodialysis: Improvement in quality of life and reduction in true cost of haemodialysis. Aust New Zealand J Med. 1991;21:693-700.
17. Levin NW, Lazarus JM, Nissenson AR. National cooperative rHu erythropoietin study in patients with chronic renal failure - an interim report. Am J Kidney Dis. 1993;22(Suppl 1):3-12.
18. McClellan WM, Anson C, Birkeli K, Tuttle E. Functional status and quality of life: Predictors of early mortality among patients entering treatment for end stage renal disease. J Clin Epidemiol. 1991;44: 83-89.
19. Parfrey PS, Vavasour H, Bullock M, et al. Development of a health questionnaire specific for end-stage renal disease. Nephron. 1989;52:20-28.
20. Rozenbaum EA, Pliskin JS, Barnoon S, Chaimovitz C. Comparative study of costs and quality of life of chronic ambulatory peritoneal dialysis and hemodialysis patients in Israel. Isr J Med Sci. 1985; 21:335-339.
21. Rozenbaum EA, Chaimovitz C, Bearman JE. Quality of life of patients on chronic dialysis. Isr J Med Sci. 1984;20:104-108.
22. Seedat YK, Macintosh CG, Subban JV. Quality of life for patients in an end-stage renal disease programme. S Afr Med J. 1987;71:500-504.
23. Wolcott DL, Nissenson AR, Landsverk J. Quality of life in chronic dialysis patients: Factors unrelated to dialysis modality. Gen Hosp Psychiatry. 1988;10:267-277.
24. Binik YM, Devins GM. Transplant failure does not compromise quality of life in end-stage renal disease. Int J Psychiatry Med. 1987;16:281-292.
25. Devins GM, Mann J, Mandin H, et al. Psychosocial predictors of survival in end-stage renal disease. J Intern Med. 1990; 178:127-133.
26. Koch U, Muthny FA. Quality of life in patients with end-stage renal disease in relation to the method of treatment. Psychother Psychosom. 1990;54:161-171.
27. Muthny FA, Koch U. Quality of life of patients with end-stage renal failure: A comparison of hemodialysis, CAPD, and transplantation. Contrib Nephrol. 1991; 89:265-273.
28. Schneider MS, Friend R, Whitaker P, Wadhwa NK. Fluid noncompliance and symptomatology in end-stage renal disease: Cognitive and emotional variables. Health Psychol. 1991;10:209-215.
29. Wolcott DL, Nissenson AR. Quality of life in chronic dialysis patients: A critical comparison of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Am J Kidney Dis. 1988;11:402-412.
30. Auer J, Gokal R, Stout JP, et al. The Oxford-Manchester study of dialysis patients: Age, risk factors and treatment method in relation to quality of life. Scand J Urol Nephrol. 1990;131:31-37.
31. Deniston OL, Luscombe FA, Buesching DP, et al. Effect of long-term epoetin beta therapy on the quality of life of hemodialysis patients. Am Soc Artificial Internal Organs Trans. 1990;36:M147-M160.
32. Revicki DA. Relationship between health utility and psychometric health status measures. Med Care. 1992;30(Suppl 5): MS274-MS282.
33. Hornberger JC, Redelmeier DA, Petersen J. Variability among methods to assess patients' well-being and consequent effect on a cost-effectiveness analysis. J Clin Epidemiol. 1992;45:505-512.
34. Bremer BA, McCauley CR, Wrona RM, Johnson JP. Quality of life in end-stage renal disease: A reexamination. Am J Kidney Dis. 1989;13:200-209.
35. Bremer BA, McCauley CR. Quality-of-life measures: Hospital interview versus home questionnaire. Health Psychol. 1986;5:171-177.
36. Deniston OL, Carpentier-Alting P, Kneisley J, et al. Assessment of quality of life in end-stage renal disease. Health Serv Res. 1989;24:555-578.
37. Johnson JP, McCauley CR, Copley JB. The quality of life of hemodialysis and transplant patients. Kidney Int. 1982;22: 286-291.
38. Kutner NG, Brogan D. Expectations and psychological needs of elderly dialysis patients. Int J Aging Hum Dev. 1990;31: 239-249.
39. Simmons RG, Anderson CR, Abress LK. Quality of life and rehabilitation differences among four end-stage renal disease therapy groups. Scand J Urol Nephrol Suppl. 1990;131:7-22.
40. Siskind MS, Lien YH. Effect of intradialytic parenteral nutrition on quality of life in hemodialysis patients. Int J Artif Organs. 1993;16:599-603.
41. Binik YM, Chowanec GD, Devins GM. Marital role strain, illness intrusiveness, and their impact on marital and individual adjustment in end-stage renal disease. Psychol Health. 1990;4:245-257.
42. Devins GM, Armstrong SJ, Mandin H, et al. Recurrent pain, illness intrusiveness, and quality of life in end-stage renal disease. Pain. 1990;42:279-285.
43. Devins GM, Mandin H, Hons RB, et al. Illness-intrusiveness and quality of life in end-stage renal disease: Comparison and stability across treatment modalities. Health Psychol. 1990;9:117-142.
44. Kutner NG, Brogan D, Gielding B, Hall WD. Older renal dialysis patients and quality of life. Dial Transplant. 1991;20: 171-175.
45. Smith MD, Hong BA, Robson AM. Diagnosis of depression in patients with end stage renal disease. Am J Med. 1985;79: 160-166.
46. Christensen AJ, Holman JM Jr, Turner CW, et al. A prospective study of quality of life in end-stage renal disease: Effects of cadaveric renal transplantation. Clin Transplant. 1992;5:40-47.
47. Craven JL, Rodin GM, Littlefield C. The Beck Depression Inventory as a screening device for major depression in renal dialysis patients. Int J Psychiatry Med. 1988; 18:365-374.
48. Sacks CR, Peterson RA, Kimmel PL. Perception of illness and depression in chronic renal disease. Am J Kidney Dis. 1990;15:31-39.
49. Poll IB, Kaplan De-Nour A. Locus of control and adjustment to chronic hemodialysis. Psychol Med. 1980;10:153-157.
50. Oldenburg B, Graham JM, Perkins RJ. Prediction of quality of life in a cohort of end-stage renal disease patients. J Clin Epidemiol. 1988;41:555-564.
51. Devins GM, Binik YM, Hutchinson TA, et al. The emotional impact of end-stage renal disease: Importance of patient's perceptions of intrusiveness and control. Int J Psychiatry Med. 1983-84;13:327-343.
52. Devins GM, Edworthy SM, Paul LC, et al. Illness intrusiveness and depressive symptoms over the adult years: Is there a differential impact across chronic conditions? Can J Behav Sci. 1993;25:400-413.
53. Devins GM, Edworthy SM, Paul LC, et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: Rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J Psychosom Res. 1993;37:163-170.
54. Devins GM, Edworthy SM, Seland TP, et al. Differences in illness intrusiveness across rheumatoid-arthritis, end-stage renal disease, and multiple sclerosis. J Nerv Ment Dis. 1993;181:377-381.
55. Bergner M, Bobbitt RA, Kressel S, et al. The Sickness Impact Profile: Conceptual formulation and methodology for the development of a health status measure. Int J Health Serv. 1976;6:393-415.
56. Bergner M. Development, testing and use of the Sickness Impact Profile. In: Walker SR, Rosser RM, eds. Quality of Life Assessment: Key Issues in the 1990s. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1993:95-110.
57. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ. 1990;300:573-578.
58. Churchill DN, Bird DR, Taylor DW, et al. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol. 1992;12:412-418.
59. Craven J, Littlefield C, Rodin G, Murray M. The Endstage Renal Disease Seventy Index (ESRD-SI). Psychol Med. 1991;21: 237-243.
60. Harris LE, Luft FC, Rudy DW, Tierney WM. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis. 1993;21:161-166.
61. Hart GL, Evans RW. The functional status of ESRD patients as measured by the Sickness Impact Profile. J Chronic Dis. 1987; 40(Suppl):117S-130S.
62. Julius M, Hawthorne VM, Carpentier-Alting P, et al. Independence in activities of daily living for end-stage renal disease patients: Biomedical and demographic correlates. Am J Kidney Dis. 1989;13:61-69.
63. Keown PA. Quality of life in end-stage renal disease patients during recombinant human erythropoietin therapy. Contrib Nephrol. 1991;88:81-89.
64. Laupacis A, Wong C, Churchill D, the Canadian Erythropoietin Study Group. The use of generic and specific quality of life measures in hemodialysis patients treated with erythropoietin. Control Clin Trials. 1991;12:168S-179S.
65. McMahon LP, Dawborn JK. Subjective quality of life assessment in hemodialysis patients at different levels of hemoglobin following use of recombinant human erythropoietin. Am J Nephrol. 1992;12: 162-169.
66. Muirhead N, Cattran DC, Zaltzman J, et al. Safety and efficacy of recombinant human erythropoietin in correcting the anemia of patients with chronic renal allograft dysfunction. J Am Soc Nephrol. 1994;5:1216-1222.
67. Kurtin PS, Davies AR, Meyer KB, et al. Patient-based health status measures in outpatient dialysis: Early experiences in developing an outcomes assessment program. Med Care. 1992;30:MS136-MS149.
68. Meyer KB, Espindle DM, DeGiacomo JM, et al. Monitoring dialysis patients' health status. Am J Kidney Dis. 1994;24: 267-279.
69. Churchill DN, Torrance GW, Taylor DW, et al. Measurement of quality of life in end-stage renal disease: The time trade-off approach. Clin Invest Med. 1987; 10:14-20.
70. Churchill DN, Wallace JE, Ludwin D, et al. A comparison of evaluative indices of quality of life and cognitive function in hemodialysis patients. Control Clin Trials. 1991;12:1598-1675.
71. Russell JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation - a prospective study. Transplant Proc. 1992;54:656-660.
72. Laupacis A, Muirhead N, Keown P, Wong C. A disease-specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron. 1992;60:302-306.
73. Morris PLP, Jones B. Life satisfaction across treatment methods for patients with end-stage renal failure. Med J Aust. 1989; 150:428-432.
74. Hays RD, Kallich JD, Mapes DS, et al. Development of the kidney disease quality of life (KDQOL™) instrument. Qual Life Res. 1994;3:329-338.
75. Ahlmen J. Quality of life: Views among patients on active treatment of uremia. Scand J Urol Nephrol Suppl. 1990;131: 43-46.
76. Atcherson E. The quality of life: A study of hemodialysis patients. Health Soc Work. 1978;3:54-69.
77. Auer J, Oliver DO, Winearls CG. The quality of life of dialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol Suppl. 1990;131: 61-65.
78. Badia X, Alonso J, Brosa M. Reliability of the Spanish version of the Nottingham Health Profile in patients with stable end-stage renal disease. Soc Sci Med. 1994;38: 153-158.
79. Barany P, Petterson E, Konarski-Svensson JK. Long-term effects on quality of life in haemodialysis patients of correction of anaemia with erythropoietin. Nephrol Dial Transplant. 1993;8:426-432.
80. Bihl MA, Ferrans CE, Powers MJ. Comparing stressors and quality of life of dialysis patients. ANNA J. 1988;15:27-28, 33-36.
81. Borgel F, Benhamou PY, Zmirou D, et al. Assessment of handicap in chronic dialysis diabetic patients (Uremidiab Section Study). Scand J Rehabil Med. 1992;24: 203-208.
82. Burton HJ, Kline SA, Lindsay RM, Heidenheim MA. The role of support in influencing outcome of end-stage renal disease. Gen Hosp Psychiatry. 1988;10: 260-266.
83. Chu NF, Ferng SH, Shieh SD. Quality of life assessment in end-stage renal disease patients with maintenance hemodialysis therapy. Chung Hua I Hsueh Tsa Chih. 1992;50:103-107.
84. Ferrans CE, Powers MJ, Kasch CR. Satisfaction with health care of hemodialysis patients. Res Nurs Health. 1987;10: 367-374.
85. Fox E, Peace K, Neale TJ, et al. Quality of life for patients with end-stage renal failure. Renal Fail. 1991;13:31-35.
86. Fukunishi I. Psychological problems of kidney transplantation: Satisfaction with dialysis therapy and desire for transplantation in hemodialysis patients. Nephron. 1993;64:146-149.
87. Hauser ML, Williams J, Strong M, et al. Predicted and actual quality of life changes following renal transplantation. ANNA J. 1991;18:295-296, 299-305.
88. Hubert GA, Stress, social support, and compliance of hemodialysis patients. J Compliance Health Care. 1989;4:57-67.
89. Hoothay F, Leary EM, DeStefano AE, Foley-Hartel TC. Life satisfaction and coping of diabetic hemodialysis patients. ANNA J. 1990;17:361-365.
90. Kutner NG, Brogan DJ. Assisted survival, aging, and rehabilitation needs: Comparison of older dialysis patients and age-matched peers. Arch Phys Med Rehabil. 1992;73:309-315.
91. Kutner NG, Brogan D, Kutner MH. End-stage renal disease treatment modality and patients' quality of life. Am J Nephrol. 1986;6:396-402.
92. Laborde JM, Powers MJ. Satisfaction with life for patients undergoing hemodialysis and patients suffering from osteoarthritis. Res Nurs Health. 1980;3:19-24.
93. Laupacis A, Pus N, Muirhead N, et al. Disease-specific questionnaire for patients with a renal transplant. Nephron. 1993;64: 226-231.
94. Levy NB, Wynbrandt GD. The quality of life on maintenance haemodialysis. Lancet. 1975;1:1328-1330.
95. Molzahn AE. The reported quality of life of selected home hemodialysis patients. ANNA J. 1991;18:173-180, 181, 194.
96. Morgan BW. The relationship between chronological age and perceived quality of life of hemodialysis patients. ANNA J. 1990;17:63-67.
97. Muirhead N, Churchill DN, Goldstein M. Comparison of subcutaneous and intravenous recombinant human erythropoietin for anemia in hemodialysis patients with significant comorbid disease. Am J Nephrol. 1992;12:303-310.
98. Park H, Bang WR, Kim SJ, et al. Quality of life of ESRD patients: Development of a tool and comparison between transplant and dialysis patients. Transplant Proc. 1992;24:1435-1437.
99. Poznanski EO, Miller E, Salguero C, Kelsh RC. Quality of life for long-term survivors of end-stage renal disease. JAMA. 1978;239:2343-2347.
100. Rozenbaum EA, Gurewicz S, Blickstein I, et al. Sexual function of women on dialysis. Dial Transplant. 1990;19:640, 643-644.
101. Soskolne V, Kaplan De-Nour A. Psychosocial adjustment of home hemodialysis, continuous ambulatory peritoneal dialysis and hospital dialysis patients and their spouses. Nephron. 1987;47: 266-273.
102. Somer E, Tucker CM. Patient life engagement, spouse marital adjustment, and dietary compliance of hemodialysis patients. J Compliance Health Care. 1988;3:57-65.
103. Tucker CM, Ziller RC, Smith WR, et al. Quality of life of patients on in-center hemodialysis versus continuous ambulatory peritoneal dialysis. Peritoneal Dial Int. 1991;11:341-346.
104. Wolcott DL, Marsh JT, La Rue A, et al. Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. Am J Kidney Dis. 1989;14: 478-485.
105. Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press; 1949:191-205.
106. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: An examination of its reliability and validity in a research setting. Cancer. 1984;53:2002-2007.
107. Schaafsma J, Osoba D. The Karnofsky Performance Status scale re-examined: A cross-validation with the EORTC-C30. Qual Life Res. 1994;3:413-424.
108. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol. 1984;2:187-193.
109. Campbell A, Converse PE, Rodgers WL. The Quality of American Life. New York: Russell Sage Foundation; 1976.
110. Bradburn N. The Structure of Psychological Well-Being. Chicago: Aldine Publishing Company; 1969.
111. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
112. Rosenberg M. Society and the Adolescent Self-Image. Princeton, NJ: Princeton University Press; 1967.
113. Rotter JB. Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr. 1966;80: 1-28.
114. Craig AR, Franklin JA, Andrews G. A scale to measure locus of control of behaviour. Br J Med Psychol. 1984;57: 173-180.
115. Guadagnoli E, Nordberg P, Mor V. Social interaction tests and scales. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, Second Edition. Philadelphia, PA: Lippincott-Raven Publishers; 1996:97-107.
116. Kaplan De-Nour A. Renal replacement therapies. In: Spilker B, ed. Quality of Life Assessments in Clinical Trials. New York: Raven Press; 1990:381-389.
117. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). Med Care. 1992;30:473-483.
118. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ. 1993;2:217-227.
119. Hays RD, Hayashi T. Beyond internal consistency reliability: Rationale and user's guide for multitrait scaling analysis program on the microcomputer. Behav Res Meth Instruments Computers. 1990;22:167-175.
120. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: Manual and Interpretation Guide. Boston: The Health Institute; 1993.
121. McHorney CA, Ware JE, Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Med Care. 1992;30:MS253-MS265.
122. McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): III. Tests of data quality, scaling assumptions, and validity among diverse patient groups. Med Care. 1994;32:40-66.
123. Torrance GW, Thomas WH, Sackett DL. A utility maximization model for evaluation of health care programmes. Health Serv Res. 1972;7:118-133.
124. Jette AM, Davies AR, Cleary PD, et al. The functional status questionnaire: Reliability and validity when used in primary care. J Gen Intern Med. 1986; 1:143-149.
125. Sherbourne CD. Social functioning: Sexual problems measures. In: Stewart AL, Ware JE, eds. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992:194-204.
126. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: Development and final revision of a health status measure. Med Care. 1981; 19:787-805.
127. Devinsky O, Vickery BG, Cramer J, et al. Development of the Quality of Life in Epilepsy (QOLTE) Inventory. Epilepsia. 1995;36:1089-1104.
128. Hays RD, Kallich JD, Mapes DL, et al. Kidney Disease Quality of Life Short Form (KDQOL-SF™), Version 1.2. Santa Monica, Calif: RAND Corporation; 1995:7928.
129. Kutner NG. Assessing end-stage renal disease patients' functioning and wellbeing: Measurement approaches and implications for clinical practice. Am J Kidney Dis. 1994;24:321-333.